Niue Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Niue Health Report.

Press releases published on June 4, 2026

Jun. 4, 2026

Aja Health and Wellness Inc. Announces Agreement for the Sale of Assets of GOeVisit Service

Indeterminate GlobeNewswire

Jun. 4, 2026

NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters’ Option

Indeterminate GlobeNewswire

Jun. 4, 2026

Eledon Announces Presentation of Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at American Diabetes Association (ADA) 2026 Scientific Sessions

Indeterminate GlobeNewswire

Jun. 4, 2026

TOMI Expands European Footprint with New Regulatory Approvals for Binary Ionization Technology

Indeterminate GlobeNewswire

Jun. 4, 2026

GILEAD SCIENCES AND LAKEFRONT COMPLETE ACQUISITION OF OURO MEDICINES TO FURTHER EXPAND INFLAMMATION PIPELINE

Indeterminate GlobeNewswire

Jun. 4, 2026

GILEAD SCIENCES EN LAKEFRONT RONDEN DE OVERNAME VAN OURO MEDICINES AF OM DE PIJPLIJN OP HET GEBIED VAN ONTSTEKINGEN VERDER UIT TE BREIDEN

Indeterminate GlobeNewswire

Jun. 4, 2026

BIO GREEN MED SOLUTION, INC. ANNOUNCES BUSINESS COMBINATION AGREEMENT TO ACQUIRE FUTURE NRG SDN. BHD. 

Indeterminate GlobeNewswire

Jun. 4, 2026

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 4, 2026

Lyell Immunopharma to Present Phase 1/2 Safety and Translational Data for Ronde-Cel in Large B-Cell Lymphoma at the European Hematology Association 2026 Congress

Indeterminate GlobeNewswire

Jun. 4, 2026

Nyxoah Announces Proposed Offering of Ordinary Shares

Indeterminate GlobeNewswire

Jun. 4, 2026

Nyxoah Enters New Chapter of Long Term Value Creation

Indeterminate GlobeNewswire

Jun. 4, 2026

Nyxoah Entre dans une Nouvelle Phase de Création de Valeur à Long Terme

Indeterminate GlobeNewswire

Jun. 4, 2026

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 4, 2026

Praxis Precision Medicines to Participate in Goldmans Sachs 47th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

Jun. 4, 2026

[Latest] Leapfrogging Health Market Size Will Attain USD 2671 Million by 2034 Registering a Promising CAGR of 11.2% - Exclusive Report by ZMR | Global Leapfrogging Health Market Size, Share, Trends Analysis Report

Indeterminate GlobeNewswire

Jun. 4, 2026

Seven Arrows Recovery Expands Public Education Efforts Around Forward-Facing, Nervous System Centred Addiction Treatment

Indeterminate GlobeNewswire

Jun. 4, 2026

Oncovita presents promising preclinical data on MVdeltaC, a novel onco-immunotherapy at EACR, 8-11 June 2026, in Budapest

Indeterminate GlobeNewswire

Jun. 4, 2026

Nika Pharmaceuticals, Inc. (OTCQB: NIKA) June 2026 Update

Indeterminate GlobeNewswire

Jun. 4, 2026

NMDP Celebrates Milestone 150,000th Transplant Representing Nearly Four Decades of Hope, Innovation and Second Chances

Indeterminate GlobeNewswire

Jun. 4, 2026

MAIA Biotechnology Reports Strong Enrollment and Dosing Momentum in Pivotal Phase 3 Non-Small Cell Lung Cancer Trial

Indeterminate GlobeNewswire